Nationally recognized as the third-largest biopharma hub in the country, and home to thriving industry clusters including technology, defense, and satellite and advanced communications, Montgomery County continues to attract global brands, generate high-quality and high-paying jobs, and drive economic growth.
Recent investments from global industry leaders highlight this continued momentum.
This past March, Samsung Biologics had its official ribbon cutting in Rockville. The Korean contract development and manufacturing leader expanded into the U.S. market through its acquisition of the former Human Genome Sciences facility in Rockville. The acquisition will retain more than 500 jobs and marks Samsung Biologics’ first U.S.-based manufacturing site, further cementing Montgomery County’s position as a premier destination for life sciences companies of all sizes. “During our international trade mission last year, we met with the Samsung Biologics team in Seoul to discuss the economic momentum in Maryland. Today’s ribbon cutting is the realization of that meeting and our state’s momentum,” said Maryland Governor Wes Moore. “South Korea’s largest biotech company is opening its first U.S. manufacturing facility here in Maryland. In the state of Maryland, we are delivering for our people and not playing for second.”
Last October, biopharmaceutical giant AstraZeneca, headquartered in Gaithersburg since 2013, announced that it will build another state-of-the art facility, also in Gaithersburg. This new facility, which follows the opening of the company’s $300 million cell therapy manufacturing facility opened in Rockville last spring, will create 100 new jobs and continue to expand the company’s R&D footprint in the County.
With access to top talent and an innovation-driven ecosystem, Montgomery County companies shaping the industries of the future are thriving. X-energy, a developer of next-generation nuclear reactor and fuel technology, launched its initial public offering on April 24. Within days of going public, the company reached a valuation of $11.9 billion. The announcement followed a consolidation of its two Rockville offices into a new 125,000-square-foot headquarters at the Washingtonian Center in Gaithersburg last summer. The company plans to retain 260 full-time employees and create more than 525 high-skilled jobs over the next six years.
Arcellx, founded at the County’s Germantown Innovation Center in 2015, was recently acquired by biopharmaceutical company and leader in HIV and cancer cell therapies Gilead Sciences for approximately $7.8 billion, Gilead’s largest acquisition since 2020. The transaction marks a significant moment not only for the company but also for the region’s life sciences ecosystem, demonstrating how companies can launch, scale, and achieve major success within the County, which is filled with key partners, including 18 federal agency headquarters and 36 federal labs.
Rounding out a strong period of economic wins in Montgomery County, Finnish climate intelligence leader Vaisala Xweather opened a new office in Gaithersburg with 20 employees and plans to hire more—another example of Montgomery County’s growing appeal to foreign companies looking to leverage the County’s assets and strategic location to expand and establish their footprint in the U.S.
Fueling investment activity in the County, state and local partner coordination ensures that economic development initiatives continue to support businesses at every growth stage. In Montgomery County, every $1 invested in economic development sees an average return of $11.48 in tax revenue, job creation, and private investment, and more than $138 in total economic impact across the local economy. The opportunity ahead for the County is clear: from life sciences, advanced technology, and clean energy, new economic activity helps strengthen the local economy and position Montgomery County as one of the most dynamic and attractive business destinations in the nation.
